![The Pharmaceutical Journal on Twitter: "GlaxoSmithKline revises colour and labelling of Relvar Ellipta inhaler http://t.co/QWxnpG3RTm http://t.co/IYC7sT7b2E" / Twitter The Pharmaceutical Journal on Twitter: "GlaxoSmithKline revises colour and labelling of Relvar Ellipta inhaler http://t.co/QWxnpG3RTm http://t.co/IYC7sT7b2E" / Twitter](https://pbs.twimg.com/media/B4qAXeiCEAAgHOm.jpg)
The Pharmaceutical Journal on Twitter: "GlaxoSmithKline revises colour and labelling of Relvar Ellipta inhaler http://t.co/QWxnpG3RTm http://t.co/IYC7sT7b2E" / Twitter
![Relvar Ellipta 200/25 Mcg Inhaler 30 Dose1's | Wellcare Online Pharmacy - Qatar | Buy Medicines, Beauty, Hair & Skin Care products and more | WellcareOnline.com Relvar Ellipta 200/25 Mcg Inhaler 30 Dose1's | Wellcare Online Pharmacy - Qatar | Buy Medicines, Beauty, Hair & Skin Care products and more | WellcareOnline.com](https://wellcareonline.com/img/products/52365/52365-A.jpg)
Relvar Ellipta 200/25 Mcg Inhaler 30 Dose1's | Wellcare Online Pharmacy - Qatar | Buy Medicines, Beauty, Hair & Skin Care products and more | WellcareOnline.com
![GSK's Breo approved in Europe, COPD market may be underestimated - MM+M - Medical Marketing and Media GSK's Breo approved in Europe, COPD market may be underestimated - MM+M - Medical Marketing and Media](https://www.mmm-online.com/wp-content/uploads/sites/2/2018/07/breo_7_-_trade-opened-inhaler-_496393.jpg)
GSK's Breo approved in Europe, COPD market may be underestimated - MM+M - Medical Marketing and Media
![Positive Results for Relvar® Ellipta® Lung Function Study in Patients with Well-Controlled Asthma - EMG Positive Results for Relvar® Ellipta® Lung Function Study in Patients with Well-Controlled Asthma - EMG](https://emj.emg-health.com/wp-content/uploads/sites/2/2017/05/Relvar-Ellipta-Significantly...-940x566.jpg)